[go: up one dir, main page]

DE60238801D1 - Zelltrennungszusammensetzungen und -verfahren - Google Patents

Zelltrennungszusammensetzungen und -verfahren

Info

Publication number
DE60238801D1
DE60238801D1 DE60238801T DE60238801T DE60238801D1 DE 60238801 D1 DE60238801 D1 DE 60238801D1 DE 60238801 T DE60238801 T DE 60238801T DE 60238801 T DE60238801 T DE 60238801T DE 60238801 D1 DE60238801 D1 DE 60238801D1
Authority
DE
Germany
Prior art keywords
methods
cell separation
separation compositions
compositions
reagents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60238801T
Other languages
English (en)
Inventor
Daniel P Collins
David M Shaut
Joel H Hapke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioe LLC
Original Assignee
Bioe LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioe LLC filed Critical Bioe LLC
Application granted granted Critical
Publication of DE60238801D1 publication Critical patent/DE60238801D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/539—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody involving precipitating reagent, e.g. ammonium sulfate
    • G01N33/541—Double or second antibody, i.e. precipitating antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/101666—Particle count or volume standard or control [e.g., platelet count standards, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Ecology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cell Separators (AREA)
  • Processing Of Solid Wastes (AREA)
DE60238801T 2001-04-10 2002-03-07 Zelltrennungszusammensetzungen und -verfahren Expired - Lifetime DE60238801D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28282301P 2001-04-10 2001-04-10

Publications (1)

Publication Number Publication Date
DE60238801D1 true DE60238801D1 (de) 2011-02-10

Family

ID=23083276

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60238801T Expired - Lifetime DE60238801D1 (de) 2001-04-10 2002-03-07 Zelltrennungszusammensetzungen und -verfahren

Country Status (12)

Country Link
US (2) US7160723B2 (de)
EP (2) EP1377353A4 (de)
JP (2) JP4212898B2 (de)
CN (1) CN1327927C (de)
AT (1) ATE493186T1 (de)
AU (1) AU2002255678B2 (de)
CA (1) CA2442577C (de)
DE (1) DE60238801D1 (de)
IL (2) IL158171A0 (de)
MX (1) MXPA03009258A (de)
RU (1) RU2292555C2 (de)
WO (1) WO2002083262A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040242520A1 (en) * 1997-09-06 2004-12-02 Mayo Foundation For Medical Education And Research, A Minnesota Corporation Expression of immonogenic substances
EP1377353A4 (de) 2001-04-10 2005-08-31 Bioergonomics Inc Zelltrennungszusammensetzungen und -verfahren
US7316932B2 (en) * 2001-10-01 2008-01-08 Stemcell Technologies Inc. Method for separating cells
WO2004029208A2 (en) * 2002-09-27 2004-04-08 Bioe, Inc. Cell separation compositions and methods
ATE510005T1 (de) 2003-06-27 2011-06-15 Univ Laval Verfahren zur isolierung von zellen aus der nabelschnur
US7622108B2 (en) * 2004-04-23 2009-11-24 Bioe, Inc. Multi-lineage progenitor cells
WO2005108559A2 (en) * 2004-04-23 2005-11-17 Bioe, Inc. Multi-lineage progenitor cells
CA2646491A1 (en) * 2006-04-17 2007-10-25 Bioe, Inc. Differentiation of multi-lineage progenitor cells to respiratory epithelial cells
US7598089B2 (en) * 2006-04-19 2009-10-06 Bioe, Inc. Methods and compositions for separating cells
EP2527839A3 (de) * 2006-05-02 2012-12-26 Therakos, Inc. Methoden und Reagenzien zur Feststellung einer Prädisposition für eine Transplantations-assoziierte Mortalität
US7713688B2 (en) 2007-01-26 2010-05-11 Bioe, Llc Methods and compositions for depleting specific cell populations from blood tissues
US20100081121A1 (en) * 2007-02-08 2010-04-01 Ge Healthcare Bio-Sciences Ab Media and method for cell separation
WO2008153802A1 (en) * 2007-05-29 2008-12-18 Eusa Pharma, Inc. Ex-vivo treatment of cancer using psma and antibodies thereto
JP5210551B2 (ja) * 2007-06-19 2013-06-12 ベックマン コールター バイオメディカル リミテッド 赤血球標識用磁性粒子
US20090029463A1 (en) * 2007-07-25 2009-01-29 Bioe, Inc. Differentiation of Multi-Lineage Progenitor Cells to Chondrocytes
US8834887B2 (en) * 2007-09-26 2014-09-16 National Cerebral And Cardiovascular Center Drug for suppressing pathogen occurring in vivo
US20090291494A1 (en) * 2008-05-21 2009-11-26 Bioe, Inc. Differentiation of Multi-Lineage Progenitor Cells to Pancreatic Cells
NZ590555A (en) * 2008-08-04 2012-11-30 Synmed Res Gmbh Method for characterizing, in particular for quantifying, molecular markers that are intracellularly absorbed from tissues by blood macrophages that are recirculated from the tissues into the circulatory system
CN101885770B (zh) * 2009-05-12 2014-07-30 成都生物制品研究所有限责任公司 一种特异性结合cd15的全人源抗体及应用
US9518087B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US9850296B2 (en) 2010-08-10 2017-12-26 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US9517257B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
WO2012061291A2 (en) * 2010-11-01 2012-05-10 Bioe Llc Methods and compositions for cell separation of blood tissues
WO2012083020A2 (en) 2010-12-15 2012-06-21 Cytosed, Inc. Antibody-linked immuno-sedimentation agent and method of isolating a target from a sample using same
CN102839152A (zh) * 2011-06-20 2012-12-26 中国科学院上海生命科学研究院 一种快速高效获得抗原特异性b细胞的方法
EP2597153B1 (de) 2011-11-25 2016-10-05 Miltenyi Biotec GmbH Zelltrennverfahren
EP3097187B1 (de) * 2014-01-21 2018-07-04 Stemcell Technologies Inc. Verfahren zur trennung von zielentitäten aus einer probe mittels einer zusammensetzung aus monospezifischen tetrameren, an eine oberfläche gekoppelten antikörperkomplexen
US10953101B2 (en) 2014-02-21 2021-03-23 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US10046056B2 (en) 2014-02-21 2018-08-14 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US10946079B2 (en) 2014-02-21 2021-03-16 Ecole Polytechnique Federale De Lausanne Glycotargeting therapeutics
SG10202010936RA (en) 2014-02-21 2020-12-30 Ecole Polytecnique Fed De Lausanne Epfl Epfl Tto Glycotargeting therapeutics
EP2985289A1 (de) * 2014-08-14 2016-02-17 Miltenyi Biotec GmbH Abreicherung von Mauszellen zur generischen Isolierung humaner Zellen nach einer Xenotransplantation
EP3037170A1 (de) 2014-12-27 2016-06-29 Miltenyi Biotec GmbH Multisort-Zelltrennverfahren
US10426796B2 (en) 2016-06-13 2019-10-01 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
US10456423B2 (en) 2016-06-13 2019-10-29 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
WO2018232176A1 (en) 2017-06-16 2018-12-20 The University Of Chicago Compositions and methods for inducing immune tolerance
WO2019217628A1 (en) 2018-05-09 2019-11-14 The University Of Chicago Compositions and methods concerning immune tolerance
CN111235104A (zh) * 2020-03-30 2020-06-05 山东省立医院 一种孕妇外周血胎儿有核红细胞分离纯化方法及分离仪

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US6048715A (en) 1988-07-08 2000-04-11 Univ. Of British Columbia Two-phase partition affinity separation system and affinity separated cell-containing composition
US5397479A (en) * 1993-04-26 1995-03-14 International Remote Imaging Systems, Inc. Composition and method for enrichment of white blood cells from whole human blood
US5514340A (en) * 1994-01-24 1996-05-07 Magnetix Biotechnology, Inc. Device for separating magnetically labelled cells
US5840502A (en) * 1994-08-31 1998-11-24 Activated Cell Therapy, Inc. Methods for enriching specific cell-types by density gradient centrifugation
US6117985A (en) * 1995-06-16 2000-09-12 Stemcell Technologies Inc. Antibody compositions for preparing enriched cell preparations
US5877299A (en) 1995-06-16 1999-03-02 Stemcell Technologies Inc. Methods for preparing enriched human hematopoietic cell preparations
US6146628A (en) 1995-07-11 2000-11-14 Regents Of The University Of Minnesota And Rutgers Biotherapeutic agents comprising recombinant PAP and PAP mutants
US5773224A (en) * 1996-02-12 1998-06-30 Grandics; Peter Immunoselection system for cell elution
JP4719326B2 (ja) 1996-08-15 2011-07-06 司 松元 赤血球の分画法
AU4101697A (en) 1996-11-22 1998-05-28 Robert A. Levine Process for enhancing the aggregation and/or agglutination of erythrocytes prior to centrifugation
WO1998032840A1 (en) * 1997-01-24 1998-07-30 Asahi Medical Co., Ltd. Method for separating cells
DE69834809T2 (de) * 1997-04-08 2007-05-16 Pall Corp. Verfahren zur gewinnung von seltenen zellen aus blutprodukten
US6491917B1 (en) * 1998-07-31 2002-12-10 Stemcell Technologies Inc. Antibody composition for debulking blood and bone marrow samples from CML patients
US6153113A (en) * 1999-02-22 2000-11-28 Cobe Laboratories, Inc. Method for using ligands in particle separation
US7135335B2 (en) 1999-05-28 2006-11-14 Stemcell Technologies Inc. Method for separating cells using immunorosettes
EP1185867B1 (de) 1999-05-28 2005-03-30 Stemcell Technologies Inc. Verfahren zur zellseparation unter verwendung von immunorosetten
EP1377353A4 (de) 2001-04-10 2005-08-31 Bioergonomics Inc Zelltrennungszusammensetzungen und -verfahren
US7855318B2 (en) 2001-11-13 2010-12-21 U.S. Smokeless Tobacco Company Cloning of cytochrome P450 genes from Nicotiana
WO2004029208A2 (en) * 2002-09-27 2004-04-08 Bioe, Inc. Cell separation compositions and methods
US7713688B2 (en) * 2007-01-26 2010-05-11 Bioe, Llc Methods and compositions for depleting specific cell populations from blood tissues

Also Published As

Publication number Publication date
IL158171A (en) 2012-09-24
RU2292555C2 (ru) 2007-01-27
JP2008289506A (ja) 2008-12-04
AU2002255678B2 (en) 2008-05-08
US7476547B2 (en) 2009-01-13
CA2442577A1 (en) 2002-10-24
US20070154961A1 (en) 2007-07-05
JP2004526452A (ja) 2004-09-02
EP1916297A2 (de) 2008-04-30
EP1916297A3 (de) 2008-05-14
US7160723B2 (en) 2007-01-09
WO2002083262A1 (en) 2002-10-24
EP1916297B1 (de) 2010-12-29
RU2003132547A (ru) 2005-03-10
ATE493186T1 (de) 2011-01-15
MXPA03009258A (es) 2004-11-12
US20030027233A1 (en) 2003-02-06
CN1327927C (zh) 2007-07-25
EP1377353A1 (de) 2004-01-07
JP4212898B2 (ja) 2009-01-21
EP1377353A4 (de) 2005-08-31
IL158171A0 (en) 2004-03-28
CN1658940A (zh) 2005-08-24
CA2442577C (en) 2011-08-30

Similar Documents

Publication Publication Date Title
ATE493186T1 (de) Zelltrennungszusammensetzungen und -verfahren
DK1553832T3 (da) Præparater og fremgangsmåder til celleseparering
ATE536187T1 (de) Hla-klasse-i- und -klasse-ii-bindende peptide und ihre verwendungen
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
DE69939945D1 (de) Verfahren zur isolierung von stammzellen
WO2004111075A3 (en) Alternative reading frame polypeptides for treatment
WO2004065015A3 (en) Magnetic separator
DE60137203D1 (de) Poröse ferro- oder ferrimagnetische glasteilchen für molekültrennung
ATE519536T1 (de) Methode zum trennen von zellen
WO2003020877A3 (en) Staining and sorting genomes and chromosomes using sequence-specific polyamides
DK1144620T3 (da) Magnetiske partikler til rensning af nucleinsyrer
NO20065084L (no) Interferon-alfa polypeptider og konjugater
WO2002082083A1 (en) Electrophoresis
WO2004055491A8 (en) Novel method for sequence determination using nmr
EP2117592A4 (de) Verfahren und zusammensetzung zur entfernung spezifischer zellpopulationen aus blutgeweben
DE60106469D1 (de) Verfahren zur Herstellung von genetisch veränderten Lymphozyten Vorläuferzellen von Wirbeltieren und deren Gebrauch zur Produktion von heterologen Bindeproteinen
WO2007127659A3 (en) Methods and compositions for separating cells
WO2002064666A3 (de) Polyphosphazen-haltige substrate als matrize und mit mikrostrukturierter oberfläche
PT1763586E (pt) Nova sequência para melhorar a expressão de ácido nucleico
PT1509344E (pt) Processo para a descontaminacao de solos
WO2002090989A3 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
WO2004031358A3 (en) Genetically engineered p30 antigen, improved antigen cocktail, and uses thereof
DE10196610T1 (de) Vorrichtung zur Sortierung von Holzschnitzeln in separate Fraktionen
WO2004016743A3 (en) Culturing anaplasma
AU2002360791A1 (en) Method of enhancing immunogenicity by covalent linkage of antigens to proteins on the surface of dendritic cells